Anatomic Stage IV Breast Cancer AJCC v8 Recruiting Phase 2 Trials for Letrozole (DB01006)

DBCOND0109665 (Anatomic Stage IV Breast Cancer AJCC v8)Recruiting2 IdentifierTitlePurposeDrugs
NCT04256941Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT StudyTreatment
NCT03691493Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone MetastasisTreatment